Comparative Genomic Analysis of Clinical Strains of Campylobacter jejuni from South Africa by Quiñones, Beatriz et al.
Comparative Genomic Analysis of Clinical Strains of
Campylobacter jejuni from South Africa
Beatriz Quin ˜ones
1*, Magalie R. Guilhabert
2, William G. Miller
1, Robert E. Mandrell
1, Albert J. Lastovica
3,
Craig T. Parker
1*
1United States Department of Agriculture-Agricultural Research Service, Produce Safety and Microbiology Research Unit, Albany, California, United States of America,
2AgraQuest, Inc., Davis, California, United States of America, 3Department of Biotechnology, University of the Western Cape, Bellville, South Africa
Abstract
Background: Campylobacter jejuni is a common cause of acute gastroenteritis and is also associated with the post-infectious
neuropathies, Guillain-Barre ´ and Miller Fisher syndromes. In the Cape Town area of South Africa, C. jejuni strains with Penner
heat-stable (HS) serotype HS:41 have been observed to be overrepresented among cases of Guillain-Barre ´ syndrome. The
present study examined the genetic content of a collection of 32 South African C. jejuni strains with different serotypes,
including 13 HS:41 strains, that were recovered from patients with enteritis, Guillain-Barre ´ or Miller Fisher syndromes. The
sequence-based typing methods, multilocus sequence typing and DNA microarrays, were employed to potentially identify
distinguishing features within the genomes of these C. jejuni strains with various disease outcomes.
Methodology/Principal Findings: Comparative genomic analyses demonstrated that the HS:41 South African strains were
clearly distinct from the other South African strains. Further DNA microarray analysis demonstrated that the HS:41 strains
from South African patients with the Guillain-Barre ´ syndrome or enteritis were highly similar in gene content. Interestingly,
the South African HS:41 strains were distinct in gene content when compared to HS:41 strains from other geographical
locations due to the presence of genomic islands, referred to as Campylobacter jejuni integrated elements (CJIEs). Only the
integrated element CJIE1, a Campylobacter Mu-like prophage, was present in the South African HS:41 strains whereas this
element was absent in two closely-related HS:41 strains from Mexico. A more distantly-related HS:41 strain from Canada
possessed both integrated elements CJIE1 and CJIE2.
Conclusion/Significance: These findings demonstrate that CJIEs may contribute to the differentiation of closely-related C.
jejuni strains. In addition, the presence of bacteriophage-related genes in CJIE1 may contribute to the genomic diversity of
C. jejuni strains. This comparative genomic analysis of C. jejuni provides fundamental information that potentially could lead
to improved methods for analyzing the epidemiology of disease outbreaks.
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Introduction
Illnesses caused by bacterial foodborne pathogens continue to be
a serious health issue worldwide. In laboratory-confirmed cases of
infection, Campylobacter jejuni is considered to be one of the most
significant bacterial causes of human gastroenteritis [1–3]. The
majority of C. jejuni infections result in an acute, self-limited
gastrointestinal illness. However, in a small number of patients, C.
jejuni infection is followed by complications, including septicaemia
[4] and the development of the autoimmune neuropathies,
Guillain-Barre ´ (GBS) and Miller-Fisher (MFS) syndromes [5–7].
The development of these autoimmune neuropathies after C. jejuni
infection is thought to be related to sialylated lipooligosaccharides
(LOS) on the cell surface of C. jejuni that exhibit molecular mimicry
with gangliosides on peripheral nerves [8–11]. The range of C. jejuni
disease outcomes, extending from acute inflammatory diarrhea to
the induction of the autoimmune neuropathies, could be associated
with the differential expression of virulence factors in C. jejuni
strains. Additionally, the broad variability in the severity and
spectrum of clinical symptoms in GBS patients suggests that host
susceptibility may play a substantial role in disease development
[12,13].
Recent studies have characterized collections of strains from
patients with GBS in search of a specific C. jejuni genotype
responsible for the development of this neuropathy. C. jejuni strains
from GBS cases, with Penner heat-stable (HS) serotypes HS:19
and HS:41, have been shown to be overrepresented in Japan and
South Africa, respectively [14–17]. Further genetic characteriza-
tion of GBS-associated strains with HS:41 and HS:19 demon-
strated that these serotypes represent clonal populations [18,19],
suggesting that specific virulence traits relevant to the onset of
GBS may be present in strains with these serotypes. Although
strains with other common serotypes have been isolated from
patients with GBS, the clustering of GBS-associated strains into
specific serotypes has not been observed to occur in all worldwide
geographical locations [20,21].
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from capsular polysaccharide, the Penner serotyping determinant
[22], is thought to be C. jejuni LOS. In most patients who develop
GBS after C. jejuni enteritis, an induction of their immune response
occurs possibly due to anti-C. jejuni LOS antibodies that cross-react
with ganglioside epitopes on neural tissues [7]. In particular, LOS
locus classes A, B, and C contain genes involved in the biosynthesis
and transfer of sialic acid, an essential component of gangliosides
[23,24], and certain genes in the biosynthesis of these specific LOS
classes are proposed to be associated with the induction of the
immune response [8,10,11,25]. Further analyses demonstrated
that a high frequency of GBS-associated strains possessed LOS
locus class A [8,9,26,27] while MFS-associated strains had LOS
locus class B [8,26]. Potentially, a comparative genomic study of a
highly-similar collection of C. jejuni strains associated with various
disease outcomes could lead to the discovery of those determinants
that may contribute to the development of GBS.
Various sequence-based typing methods, including multilocus
sequence typing (MLST) [28–34], DNA sequencing of certain
virulence loci [24,27,35] and comparative gene indexing by DNA
microarrays [36–42], have been exploited to both identify
differences between C. jejuni strains and potential relationships
between molecular markers and disease outcomes. In particular,
gene indexing studies, by using whole-genome microarrays of C.
jejuni strain NCTC 11168, have demonstrated several regions of
intraspecies genome hypervariability between strains of C. jejuni,
including the LOS, capsular polysaccharide, flagellar biosynthetic
and restriction-modification loci [36–42].
The genome sequence data of C. jejuni strain RM1221 have
provided additional information of intraspecies genome diversity
in C. jejuni [43]. The genome of strain RM1221 is syntenic with the
genome of C. jejuni NCTC 11168 except for four genomic islands,
referred to as Campylobacter jejuni integrated elements (CJIEs), and
small gene clusters. Recently, a comparative genomic analysis by
using DNA microarrays demonstrated that these CJIEs were
present in C. jejuni strains from various geographical locations and
from both clinical and veterinary sources [40], and the coding
sequences within the CJIEs from these C. jejuni strains were highly
divergent when compared to strain RM1221 [40,44]. Based on
these findings, the CJIEs are postulated to be additional
hypervariable genomic regions that may contribute to increase
the diversity of C. jejuni strains [40].
In the present study, a comparative analysis was performed to
examine the genetic content of a collection of C. jejuni strains
recovered from patients admitted to the Red Cross War Memorial
Children’s Hospital in Cape Town, South Africa. In the Cape
Town area, GBS has been estimated to occur at a high incidence
in children under 15 years of age [14,16]. Based on these findings,
it has been postulated that a severe form of GBS may be prevalent
in this area. Among C. jejuni strains from South African patients
with GBS, serotype HS:41 has been found to be overrepresented
[14,16]. In this comparative genomic analysis, sequence-based
typing methods, MLST and whole-genome DNA microarrays,
were employed to identify distinguishing features within the
genomes of South African C. jejuni strains with different serotypes
that were recovered from patients with GBS, MFS or enteritis.
Materials and Methods
Bacterial strains, growth conditions and chemicals
The C. jejuni reference and clinical strains used in this study are
shown in Table 1. The source and characteristics of the C. jejuni
strains, isolated from patients admitted to the Red Cross War
Memorial Children’s Hospital in Cape Town, South Africa, have
been described previously [14,16]. C. jejuni strains were grown at
42uC under microaerobic conditions (8% CO2,4 %O 2, 80% N2,
8% H2) on Oxoid anaerobe basal agar (Remel Inc., Lenexa, KS)
amended with 5% laked horse blood (Hema Resource and Supply
Inc., Aurora, OR). PCR enzymes and reagents were purchased
from New England Biolabs (Beverly, MA) or Epicentre Biotech-
nologies (Madison, WI). DNA sequencing chemicals and capillar-
ies were purchased from Applied Biosystems (Foster City, CA). All
other chemicals were purchased from Sigma-Aldrich Chemicals
(St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).
Multilocus sequence typing of C. jejuni strains
The C. jejuni strains in Table 1 were typed by using the C. jejuni
MLST primer sets as described previously [34,45]. The Perl
program MLSTparser [45] was used to extract allele sequences
and assign allele numbers and sequence types. All allelic sequences
were queried against the Campylobacter jejuni/coli MLST database
(http://pubmlst.org/campylobacter/) to assign numbers to alleles
already present in the database. Novel alleles and sequence types
(STs) were submitted to the MLST database to obtain new
numbers. Each novel C. jejuni ST was compared to existing C. jejuni
STs by concatenating the allelic sequences at all loci for that ST
and performing either pairwise BLASTN comparisons against
similarly concatenated C. jejuni ST sequences or performing
CLUSTALX alignments [45,46]. A dendrogram was constructed
by using the aligned concatenated sequences and the neighbor-
joining method with the Kimura two-parameter distance estima-
tion method. Subsequent phylogenetic analyses were performed
by using MEGA version 2.1, as in previous studies [46].
Construction of the C. jejuni DNA microarray
DNA fragments of individual open reading frames (ORFs) were
amplified by using the Sigma-Genosys (The Woodlands, TX) C.
jejuni ORFmer primer set specific for strain NTCT11168 coding
sequences and by using primers from Operon Technologies
(Alameda, CA) specific for unique sequences in strain RM1221, as
previously described [40]. Additional DNA fragments were
amplified from strain RM3193 (Table 1) based on the published
sequence for the serotype HS:41 capsular locus ORFs [35] and for
LOS genes from locus classes A, B, C, E and F, as in previous
studies [27]. A total of 1530, 227, 40 and 28 PCR products were
amplified from strain NCTC 11168, strain RM1221, LOS genes
and serotype HS:41 capsule genes, respectively. The PCR
products were purified on a Qiagen 8000 robot by using a
Qiaquick 96-well Biorobot kit (Qiagen, Valencia, CA) and spotted
in duplicate onto Ultra-GAPS glass slides (Corning Inc., Corning,
N. Y.) by using an OmniGrid Accent (GeneMachines, Ann Arbor,
MI), as described previously [40]. Immediately after printing, the
microarrays were UV crosslinked at 300 mJoules by using a
Stratalinker UV Crosslinker 1800 (Stratagene, La Jolla, CA) and
stored in a desiccator. Before use, microarrays were blocked with
Pronto! Pre-Hybridization Solution (Corning Inc.), according to
the manufacturer’s specifications.
Preparation and fluorescent labeling of genomic DNA
and microarray hybridization
Genomic DNA from C. jejuni was prepared as described
previously [27] or purified by using the Wizard Genomic DNA
kit (Promega, Madison, WI), according to the manufacturer’s
specifications. Each microarray hybridization reaction consisted of
genomic DNAs from the reference strains (an equal amount of
DNA from C. jejuni strain NCTC11168 and strain RM1221) and
from a test strain that were fluorescently labeled with indodicar-
Genome Diversity of C. jejuni
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examining the Penner serotype HS:41 strains, genomic DNA was
purified from the reference strain RM3193. Approximately 2 mg
of DNA was mixed with 5 ml1 0 6 NEBlot labeling buffer
containing random octadeoxyribonucleotides (New England
Biolabs, Beverly, MA) and water to a final volume of 41 ml. This
mixture was heated to 95uC for 5 min, cooled for 5 min at 4uC
and added to the remainder of the labeling reaction consisting of
5 mlo f1 0 6 dNTP labeling mix (1.2 mM each dATP, dGTP,
dCTP; 0.5 mM dTTP in 10 mM Tris pH 8.0; 1 mM EDTA)
Table 1. MLST analysis of the Campylobacter jejuni strains used in this study.
Strains
a Year Country
c Disease
d
LOS
class Penner type(s)
e ST Allele number
aspA atpA glnA gltA glyA pgm tkt
RM1221 (ATCC BAA-1062) 1996 USA Unk F HS:53 354 8 6 10 2 2 11 12
RM1862 (NCTC 11168) Unk
b UK Enteritis C HS:02 43 2515341
RM3148 (ATCC BAA-530) Unk MEX GBS A HS:41 1672 1824 2 42 5 6 9
RM3149 (ATCC BAA-529) Unk MEX GBS A HS:41 1672 1824 2 42 5 6 9
RM3193 (260.94) 1994 SA GBS A HS:41 362 1824 9 41 1 6 6
RM3194 (285.94) 1994 SA Enteritis B Unk 1471 24 6 171 2 2 89 59
RM3196 (233.94) 1994 SA GBS A HS:41 362 1824 9 41 1 6 6
RM3197 (308.95) 1995 SA GBS A HS:41 362 1824 9 41 1 6 6
RM3198 (367.95) 1995 SA GBS A HS:41 362 1824 9 41 1 6 6
RM3201 (378.96) 1996 SA Enteritis A HS:41 362 1824 9 41 1 6 6
RM3203 (16.97) 1997 SA Enteritis H HS:12 137 4171 0 44 2 7
RM3204 (20.97) 1997 SA Enteritis H HS:12 137 4171 0 44 2 7
RM3205 (199.97) 1997 SA Enteritis A HS:41 362 1824 9 41 1 6 6
RM3206 (242.98) 1998 SA MFS A HS:41 362 1824 9 41 1 6 6
RM3207 (250.97) 1997 SA Enteritis A HS:41 362 1824 9 41 1 6 6
RM3208 (1.98) 1998 SA Enteritis H HS:21 137 4171 0 44 2 7
RM3209 (24.98) 1998 SA Enteritis H HS:12 137 4171 0 44 2 7
RM3211 (96.00) 2000 SA GBS A HS:33 1472 2 127 2 42 4 90 25
RM3430 Unk CAN Unk A HS:41 41 16 8 2 16 62 3 9
RM4186 (390.96) 1996 SA Enteritis Unk Unk 354 8 6 10 2 2 11 12
RM4187 (172.03) 2003 SA Enteritis F Unk 1473 28 129 34 27 33 45 36
RM4191 (160.03) 2003 SA Enteritis G Unk 587 1824 2 49 0 2 5
RM4192 (124.03) 2003 SA Enteritis F Unk 1474 14 6 17 5 2 2 3
RM4193 (MF 321317.03) 2003 SA MFS B Unk 730 2545221
RM4194 (180.03) 2003 SA Enteritis H Unk 436 7 44 21 5 62 4 61
RM4196 (126.01) 2001 SA Enteritis B Unk 429 754121 1 1
RM4197 (MF 996.00) 2000 SA MFS F Unk 257 96246 2 45
RM4269 (367.95) 1995 SA GBS A HS:41 362 1824 9 41 1 6 6
RM4270 (287.96) 1996 SA Enteritis A HS:41 362 1824 9 41 1 6 6
RM4271 (302.96) 1996 SA Enteritis B HS:33 1043 10 7 27 33 44 10 5
RM4273 (375.96) 1996 SA Enteritis B HS:02 824 962221 1 5
RM4274 (379.96) 1996 SA Enteritis Unk HS:42 1475 26459 3 1 1 2 0 1
RM4275 (398.96) 1996 SA Enteritis H HS:37 51 7 12 17 2 15 23 3
RM4277 (422.96) 1996 SA Enteritis F HS:04,16, 43,50 52 9 6 25 2 10 22 3
RM4278 (423.96) 1996 SA Enteritis F HS:05 52 9 6 25 2 10 22 3
RM4279 (424.96) 1996 SA Enteritis H HS:37 51 7 12 17 2 15 23 3
RM4281 (1.97) 1996 SA Enteritis C Unk 19 2515321
RM4282 (18.97) 1996 SA Enteritis H HS:50, 62 51 7 12 17 2 15 23 3
aOriginal strain number is designated in parenthesis.
bUnk, unknown.
cUK, United Kingdom; USA, United States of America; SA, South Africa; MEX, Mexico; CAN, Canada.
dGBS, Guillain-Barre ´ syndrome; MFS, Miller Fisher syndrome.
ePenner heat-stable (HS) serotypes.
doi:10.1371/journal.pone.0002015.t001
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sham CyDye fluorescent nucleotides, Cy3-dUTP or Cy5-dUTP
(GE Healthcare Life Sciences Corp., Piscataway, NJ), and 5 U of
Klenow fragment (New England Biolabs). The labeling reactions
were incubated overnight at 37uC, as previously described [40].
Labeled DNA was purified from unincorporated CyDye fluores-
cent label by using Qiaquick PCR Cleanup kit (Qiagen, Valencia,
CA) and dried by vacuum.
DNA microarray hybridization and data analysis
Labeled reference and test DNAs were combined in a 45 ml
Pronto! cDNA hybridization solution (Corning Inc., Corning,
NY), heated to 95uC for 5 min and immediately centrifuged at
14,5006 g for 2 min at room temperature. Fifteen ml of this
hybridization mixture was added to each microarray and sealed
with a coverslip. The microarray slide was placed in a
hybridization chamber (Corning Inc.) and incubated at 42uC for
18 h. Following hybridization, the slides were washed and dried by
centrifugation at 3006g for 10 min before scanning, as previously
described [40]. At least two hybridization reactions were
performed for each test strain and were quantified further as
described below.
DNA microarrays were scanned by using an Axon GenePix
4000B microarray laser scanner (Molecular Devices Corporation,
Sunnyvale, CA) at 532 nm (Cy3) and 635 nm (Cy5) excitation
wavelengths with a 10 mm resolution, as described previously [40].
Briefly, after scanning of the DNA microarrays, features and local
background intensities were detected and quantified with GenePix
4.0 software (Molecular Devices). Spots were excluded from
further analysis if they contained an anomalous spot morphology
or were within regions of non-specific fluorescence. The data were
filtered by discarding spots with a reference signal lower than the
background plus 3 standard deviations of the background. Signal
intensities were corrected by subtracting the local background, and
calculating the Cy5/Cy3 ratios. To compensate for unequal dye
incorporation, data normalization was performed as described
previously [40,47]. Only half of the reference DNA (Cy5-labeled
mixture of NCTC 11168 and RM1221 DNA) hybridized to the
NCTC 11168 and RM1221 strain-specific spots, increasing the
Cy3/Cy5 ratio by twofold. Therefore, the ratios for these NCTC
11168 and RM1221 strain-specific spots were divided by 2 before
determining the status of the gene. The ratios for spots of each
individual gene were then averaged. As previously described [40],
the comparative genomic indexing analysis defined the status of a
gene as present when the Cy3/Cy5 (test/reference) intensity ratio
was .0.6, as divergent when the Cy3/Cy5 intensity ratio was
between 0.6 and 0.3, and as highly divergent or absent when the
Cy3/Cy5 intensity ratio was ,0.3. For LOS class A, B, and E
specific genes that are not present in the reference strains (NCTC
11168 and RM1221), the status of these genes was still determined
by the Cy3/Cy5 intensity ratio. Given that the Cy5 intensity
represented only nonspecific hybridization, the status of these LOS
class-specific genes was defined as present when the Cy3/Cy5
(test/reference) intensity ratio was .3, and as absent when the
Cy3/Cy5 intensity ratio was ,3. The LOS gene status was
confirmed by PCR described previously (Parker, et al., 2005). The
status for all genes was converted into trinary scores (present=2;
divergent=1; highly divergent or absent=0). The trinary scores
for all genes for each strain were further analyzed with
GeneSpring microarray analysis software version 7.3 (Agilent
Technologies, Santa Clara, CA) and subjected to average-linkage
hierarchical clustering with the standard correlation and boot-
strapping. The comparative genomic indexing analysis to assign
present or absent genes of the GBS-associated strains with HS:41
serotype was performed by using strain RM3193 as a reference
strain and the GENCOM software [41,48]. For each of these
hybridizations, the Cy5 and Cy3 signal intensities were corrected
by subtracting the local background before submission into the
GENCOM program for determining the present or absent
assignments for each gene. The microarray data has been
deposited in the NCBI Gene Expression Omnibus (GEO)
repository (http://www.ncbi.nlm.nih.gov/geo/) with the accession
number GSE9862.
Results
Multilocus sequence typing analysis of the South African
strains
To examine the genetic variation among 32 C. jejuni clinical
strains from South Africa, multilocus sequence typing (MLST) was
employed to analyze the nucleic acid sequences of seven C. jejuni
housekeeping loci (aspA, atpA (uncA), glnA, gltA, glyA, pgm, and tkt). As
shown in Table 1, a total of 18 different sequence types (ST) were
identified among these C. jejuni clinical strains. ST-51, ST-52, ST-
137 and ST-362 were represented by more than one strain, and
several strains with ST-51, ST-52 and ST-137 had different
serotypes (Table 1). In contrast, the analysis demonstrated that C.
jejuni strains from South Africa with serotype HS:41 were all
assigned ST-362. However, different sequence types were
observed for three serotype HS:41 strains from other geographical
locations, Mexico and Canada. Of particular interest, the strains
from Mexico shared 4 alleles (aspA, atpA, glnA and glyA) with the
South African HS:41 strains. To further examine the relatedness
of the serotype HS:41 strains from these two geographical
locations, a dendrogram was constructed by using the neighbor
joining method for pairwise comparisons of the concatenated
seven allele sequences (Figure 1). The phylogenetic analysis
demonstrated that the South African HS:41 strains, members of
ST-362, belong to the same clade as the two ST-1672 strains from
Mexico with a bootstrap value of 100% (Figure 1), indicating that
these strains from different geographical locations are highly
similar by MLST.
Figure 1. Dendrogram of Campylobacter jejuni sequence types,
including clinical strains from South Africa, Mexico and
Canada. The dendrogram was constructed by using the neighbor-
joining algorithm and the Kimura two-parameter distance estimation
method. Bootstrap values of .75%, generated from 500 replicates, are
shown at the nodes. The scale bar represents substitutions per site.
doi:10.1371/journal.pone.0002015.g001
Genome Diversity of C. jejuni
PLoS ONE | www.plosone.org 4 April 2008 | Volume 3 | Issue 4 | e2015Comparative genomic indexing of the South African
strains
The intraspecies genetic diversity found in the South African
clinical strains was examined at the whole-genome level by DNA
microarrays. A comparative analysis was performed with a multi-
strain C. jejuni DNA microarray based on sequence data from the
genome strains NCTC 11168 and RM1221 (see Materials and
Methods). In this microarray analysis, a hierarchical clustering was
performed to further examine the relationship among the clinical
strains by using a standard correlation function where the linkage
distance between strains is represented by branch lengths in the
resulting cluster. Analysis of the comparative microarray data
demonstrated that strains with the same sequence type clustered
together (Figure 2), demonstrating a strong correlation with our
MLST analysis. A distinct subcluster with a distance score of 0.016
was observed for all serotype HS:41 strains from South African
patients with GBS, MFS or enteritis in ST-362 (Figure 2).
Clustering next to this group with a distance score of 0.026 were
the two GBS-associated HS:41 strains from Mexico both with ST-
1672. In contrast, strains from enteritis cases with distinct
serotypes HS:12 and HS:37 in ST-137 and ST-51, respectively,
formed two separate clusters that showed divergence from the
main cluster composed of serotype HS:41 strains (Figure 2).
Using the trinary score for present, absent or divergent genes,
17.8% (314 of 1757) of the genes were absent or highly divergent
in at least one South African strain when compared to the genome
strains represented on the microarray (Figure 3). Most of the
variable genes in the South African strains were found in the
hypervariable genomic regions (Table 2), regions previously
described to be involved in capsule (region 13) and LOS (region
11) biosynthesis, flagellar modification and O-linked glycosylation
(region 12) and type I restriction-modification (region 14) [42].
Further analysis of a subset of the South African strains with the
HS:41 serotype demonstrated that genes in four hypervariable
Figure 2. Genome comparison of Campylobacter jejuni clinical strains by DNA microarrays analysis. An average linkage hierarchical
clustering of the C. jejuni strains with a distance score scale bar was compiled in GeneSpring version 7.3 with the standard correlation and
bootstrapping (see Materials and Methods). The gene status based on cutoff values of absence and presence predictions is shown color-coded: blue,
present; light blue, divergent; red, highly divergent or absent; white, no data. C. jejuni strains from South Africa with HS:41 serotype (yellow), with
other serotypes (green), or strains with HS:41 serotype from Mexico and Canada (white) are designated vertically across the bottom. GBS-associated
strains are annotated with stars; MFS-associated strains are annotated with diamonds. The four C. jejuni-integrated elements (CJIEs) and the assigned
MLST sequence type (ST) for each strain cluster is indicated.
doi:10.1371/journal.pone.0002015.g002
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strains NCTC 11168 and RM1221 (Figure 3). Interestingly, region
4 (CJE0340-CJE0355), encoding proteins involved in pantothe-
nate and biotin biosynthesis and for a molybdenum ABC
transporter (Table 2), was the only region that was highly
divergent in all HS:41 strains from South Africa and Mexico but
present in the HS:41 strain from Canada (Figure 3).
Analysis of the comparative microarray data of the LOS region
showed that all six strains from South African patients with GBS
possessed class A (Table 1). This finding correlated with previous
reports that demonstrated that the class A locus, a class that has
been associated with the GM1 ganglioside-like structure [8,9,49],
was overrepresented in GBS-associated strains [8,26,27]. In the
present study, this LOS locus class was identified also in the four
enteritis-associated strains with the HS:41 serotype (Table 1).
Similar to previous findings [50], most GBS-associated strains
examined in this study bound cholera toxin (data not shown),
which binds highly selectively to GM1 gangliosides [9,51],
demonstrating that these strains may have a similar LOS outer
core structure. In contrast, the GBS-associated strains RM3196
and RM3198 failed to bind cholera toxin. These observations
suggested that strains RM3196 and RM3198 with a class A LOS
locus may prevalently synthesize ganglioside mimics with an outer
core structure that is different from a GM1-like ganglioside, as
recently demonstrated [9]. Interestingly, the MFS-associated
strains RM3206, RM4193, and RM4197 with distinct LOS locus
classes A, B, and F, respectively, also failed to bind cholera toxin
(data not shown), as demonstrated previously in a recent study
showing a lack of cholera toxin binding by all MFS-associated
strains [50].
To identify potential differences within the genome of GBS-
associated strains, the genetic relatedness of the HS:41 South
African strains from GBS and enteritis patients was examined
further by using the GENCOM software [41,48] and the GBS-
associated strain RM3193 as a reference strain (see Materials and
Methods). In this particular analysis, the cutoff values between
divergent and similar genes were established to represent a 95%
nucleotide sequence identity for each gene examined between the
reference strain RM3193 and the remaining South African strains
with HS:41 serotype (Table 1). The regression slope had a linear
relationship between the logarithms of the red Cy5 (reference
RM3193 strain) and the green Cy3 (tested HS:41 strain)
Figure 3. Patterns of presence, absence or divergence in the 18 hypervariable regions in Campylobacter jejuni strains. A detailed
genomic analysis of the 18 hypervariable regions (Table 2) was compiled in GeneSpring version 7.3 with the standard correlation and bootstrapping
(see Materials and Methods). Each panel represents a hypervariable region, and each column corresponds to a C. jejuni strain designated vertically
across the bottom, as described in the legend to Figure 2. The gene status based on cutoff values of absence and presence predictions is shown
color-coded: blue, present; light blue, divergent; red, highly divergent or absent; white, no data.
doi:10.1371/journal.pone.0002015.g003
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genome content of these GBS- and enteritis-associated strains with
HS:41 serotype, a serotype considered to be clonal and highly
stable [19], was very similar. Based on this DNA microarray
analysis, differences in gene content could not be identified in the
HS:41 South African strains from GBS and enteritis patients.
The comparative genomic analysis further assessed for the
presence of CJIEs, genomic integrated elements initially identified
in strain RM1221 [40,43], in the C. jejuni strains from South
Africa. From the hierarchical cluster analysis that examined the
relationships among the four CJIEs for each strain, the presence of
genes in at least one of the four CJIEs was identified in each South
African strain (Figure 2). Interestingly, the clustering analysis
demonstrated that all serotype HS:41 strains from South Africa
contained most genes in the CJIE1 genomic element, as in strain
RM1221 (Figure 4), whereas genes in the other three genomic
elements, CJIE2, CJIE3, and CJIE4, were absent in all of these
strains (Figures 2 and 4). By using our trinary score for genes
present, absent or divergent in sequence (see Materials and
Methods), no distinct features in the CJIE1 element were observed
for any of the HS:41 South African strains from GBS patients
when compared to strains from enteritis patients (Figure 4).
Furthermore, the hybridization patterns for the genes in the CJIEs
were compared with serotype HS:41 strains from other geograph-
ical locations. The hierarchical analysis demonstrated the presence
of genes for both CJIE1 and CJIE2 genomic elements in strain
RM3430, a serotype HS:41 strain from Canada (Figure 4). When
compared to CJIE genes represented in the DNA microarray, both
CJIE1 and CJIE2 genes were absent in the Mexican HS:41 strains
RM3148 and RM3149 (Figure 4). These results indicated that the
inclusion of CJIE sequences, RM1221-like genomic elements, in
our microarray analysis distinguished the gene content of the
clonal HS:41 South African strains from three HS:41 strains from
Canada and Mexico.
Discussion
The present study performed a comparative genomic analysis,
by using the sequence-based typing methods MLST and DNA
microarrays, to examine the genetic polymorphism of C. jejuni
strains that were isolated from South African patients with various
disease outcomes, enteritis, GBS or MFS. The hierarchical cluster
analysis by DNA microarrays showed that C. jejuni strains with the
same sequence type clustered together. Our MLST and micro-
array analysis also demonstrated that all of the South African
strains with HS:41 serotype, a serotype considered to be clonal and
highly stable [19], are clearly distinct from the other South African
strains and that they are also distinct from other HS:41 strains
from other three strains from Canada and Mexico. Although
several reports demonstrated regions of high variability between
other strains of C. jejuni and strain NCTC 11168 [36–39,41,42],
the gene indexing analysis performed in this study, by using a
microarray containing genes from both genome strains
NCTC11168 and RM1221 [40], identified a total of 18
intraspecies hypervariable regions in the genome from the South
African strains, as previously reported for other C. jejuni strains
from various geographical locations and sources [40]. Intriguingly,
only hypervariable region 4 (CJE0340-CJE0355), encoding
proteins involved in pantothenate and biotin biosynthesis and for
a molybdenum ABC transporter, was highly divergent in all
HS:41 strains from South Africa and Mexico but present in the
HS:41 strain from Canada. A previous study documented that this
region was distinct between strain NCTC 11168 and RM1221,
and similar results were obtained when the hybridization pattern
for additional C. jejuni isolates from various locations and sources
was examined [40]. These findings have led to the proposal that
an additional level of diversity may be found in the hypervariable
region 4 [40]. Still to be determined is the role of genomic diversity
within this region and whether the divergence of these genes is
characteristic of certain serotype HS:41 strains.
Table 2. Intraspecies hypervariable regions in Campylobacter jejuni.
Region Genes
a Proposed function
1 CJE0031-CJE0035 (Cj0032-Cj0036) Type IIS restriction/modification
2 CJE0051-CJE0055 (Cj0055c-Cj0059c) Unknown
3 CJE0170-CJE0175 (Cj0177-Cj0182) Putative iron transport, biopolymer transport, putative TonB transport protein
17 CJE0308-CJE0313 (Cj0258-Cj0263) Putative zinc transport; dihydroorotase; homodimeric type
4 CJE0340–CJE0355 (Cj0294-Cj0310c) Pantothenate and biotin biosynthesis pathway; molybdenum ABC transporter
5 CJE0470-CJE0472 (Cj0421c-Cj0425) Unknown
6 CJE0530-CJE0538 (Cj0480c-Cj0490) Unknown; UxaA family hydrolase
7 CJE0666-CJE0673 (Cj0561c-Cj0571) Unknown
8 CJE0728-CJE0732 (Cj0625-Cj0629) Hydrogenase formation proteins; type III restriction/modification
9 CJE0828-CJE0844 (Cj0727-Cj0755) Phosphate regulated genes; iron uptake; TonB transport protein; ferric enterobactin uptake receptor
18 CJE0944-CJE0947 (Cj0857c-Cj0860) Unknown
10 CJE1047-CJE1056 (Cj0967-Cj0975) Unknown
11 CJE1278-CJE1281 (Cj1135-Cj1145c) Lipooligosaccharide biosynthesis
12 CJE1485-CJE1532 (Cj1293-Cj1343) Flagellar modification; O-linked glycosylation
13 CJE1601-CJE1622 (Cj1414c-Cj1449c) Capsule biosynthesis
14 CJE1714-CJE1733 (Cj1543c-Cj1563c) Type I restriction/modification; unknown
15 (Cj1677-Cj1679) Unknown
16 CJE1888-CJE1896 (Cj1717c-Cj1729c) 2-isopropylmalate synthase; isopropylmalate dehydrogenase; 3-isopropylmalate dehydratase; unknown
aThe start and end of each region is shown for genes in strain RM1221 (strain NCTC 11168) [40,42].
doi:10.1371/journal.pone.0002015.t002
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four CJIEs, identified initially in strain RM1221 [40,43],
differentiated the South African HS:41 strains from the two
closely-related HS:41 strains from Mexico. Only CJIE1, a
Campylobacter Mu-like prophage [40,43], was present in the South
African HS:41 strains whereas all four CJIEs were absent in the
HS:41 strains from Mexico. A more distantly-related HS:41 strain
from Canada possessed both CJIE1 and CJIE2. In addition, the
presence of bacteriophage-related genes in CJIE1 may probably
contribute to increasing the genomic diversity of these C. jejuni
strains. These findings demonstrated that these CJIEs are
additional regions of high variability between strains of C. jejuni
and that these genomic regions could be utilized in the
differentiation of closely-related C. jejuni strains.
The comparative analysis further investigated any potential
association between specific classes of LOS biosynthesis loci and
GBS. Our DNA microarray analysis demonstrated that all of
GBS-associated strains possessed the class A LOS whereas only
17% (4 of 24) of the enteritis-control strains also possessed this class
of LOS. Indeed, it has been speculated that the C. jejuni-induced
neuropathies are probably related to the molecular mimicry
between gangliosides in nerve tissue and LOS on the C. jejuni cell
surface [7]. Biochemical and serological studies have revealed that
GBS-associated strains exhibit ganglioside-like structures in their
LOS [50,52]. More specifically, strains possessing the class A locus
have been shown to express an LOS outer core that mimics
gangliosides [23–25], and the occurrence of the class A locus has
been correlated strongly with GBS-associated strains [8,9,26,27].
Finally, the only substantial differences between GBS-associated
and control C. jejuni strains appears to date to reside in the LOS-
biosynthetic gene locus [8,25,26,53]. Recent comparative genomic
analysis have proposed that GBS markers may be located only in
the LOS biosynthesis region [25,53,54].
Previous studies that employed MLST and DNA microarrays
could not identify GBS- specific genetic markers by comparing the
genomes of C. jejuni strains from various geographical locations,
serotypes, and disease outcomes [39,55]. Furthermore, no molecular
markers specific to the GBS syndrome were detected after analyzing
a highly clonal HS:41 population from South African patients by
using a different typing technique, high-throughput amplified
fragment length polymorphism [53]. Similar results were obtained
in the present study by using DNA microarrays to compare the
genome content of South African C. jejuni GBS-associated and
enteritis strains with the HS:41 serotype. There are several potential
reasons why no GBS-specific molecular markers in C. jejuni were
identified in this study. First, our DNA microarray was based on the
genome sequence of strains NCTC 11168 and RM1221, and genes
that are not present in these strains used to construct the microarray
will not be detected. Furthermore, single nucleotide changes that
may result in point mutations leading to biological differences, but
not detectable by DNA microarrays, may be an important factor in
the development of GBS. However, these genetic differences could
be disclosed potentially by a more detailed DNA analysis identifying
single-nucleotide polymorphisms (SNPs). Just recently, SNPs have
been used successfully for comparing entire genomes in clinically-
relevantstrainsofMycobacteriumtuberculosis[56],Helicobacterpylori [57],
E. coli [58] and S. enterica [59]. Furthermore, specific C. jejuni GBS-
features may rather involve differential expression of Campylobacter
virulence factors and could be revealed by expression analysis of
GBS-associated strains. Indeed, this approach might identify
regulatory or virulence-related genes or gene loci that represent
mechanisms important in the development of molecular mimicry
associated with GBS. Given that there is broad variability in the
severity and spectrum of clinical symptoms in GBS patients [12,13],
host-susceptibility may play a substantial role in the development of
GBS [60,61]. Thus, further characterization of the interaction
between the host and C. jejuni is needed to better understand the
pathogenesis of Campylobacter-induced GBS.
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